Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Gubatan

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Drugs|June 26, 2023
Effectiveness of Non-Budesonide Therapies in Management of Microscopic Colitis: A Systematic Review and Meta-analysisAmalie Rehde, Sebastian Kjærgaard Hendel, Carsten Bogh Juhl, et al.
Case Reports in Gastrointestinal Medicine|November 11, 2016
Hemorrhage from Extra-Antral Gastric Antral Vascular Ectasia in a Patient with Duodenal Heterotopic Gastric MucosaJohn Gubatan, Nathan Raines, Hasan Khosravi, et al.
Drugs|November 12, 2024
Immunogenicity of Therapeutic Antibodies Used for Inflammatory Bowel Disease: Treatment and Clinical ConsiderationsOle Haagen Nielsen, Alexander Hammerhøj, Mark Andrew Ainsworth, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 9, 2016
Low Serum Vitamin D During Remission Increases Risk of Clinical Relapse in Patients With Ulcerative ColitisJohn Gubatan, Shuji Mitsuhashi, Talia Zenlea, et al.
World Journal of Gastroenterology|December 10, 2021
Antimicrobial peptides and the gut microbiome in inflammatory bowel diseaseJohn Gubatan, Derek R Holman, Christopher J Puntasecca, et al.
World Journal of Gastroenterology|May 19, 2021
Artificial intelligence applications in inflammatory bowel disease: Emerging technologies and future directionsJohn Gubatan, Steven Levitte, Akshar Patel, et al.
World Journal of Gastroenterology|November 7, 2022
Immune checkpoint inhibitor-mediated colitis is associated with cancer overall survivalAlexa R Weingarden, John Gubatan, Sundeep Singh, et al.
Digestive Diseases and Sciences|March 19, 2024
Some Drugs Have Two Faces: Paradoxical Colitis in a Patient with Psoriatic Arthritis Previously Treated with Etanercept and IL-17 InhibitorsSandy Huynh, Sudharshan Achalu, Rani Berry, et al.
Cytokine|January 12, 2018
Higher serum vitamin D levels are associated with protective serum cytokine profiles in patients with ulcerative colitisJohn Gubatan, Shuji Mitsuhashi, Maria Serena Longhi, et al.
Clinical and Experimental Gastroenterology|September 1, 2021
Anti-Integrins for the Treatment of Inflammatory Bowel Disease: Current Evidence and PerspectivesJohn Gubatan, Kian Keyashian, Samuel J S Rubin, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Drugs|June 26, 2023
Effectiveness of Non-Budesonide Therapies in Management of Microscopic Colitis: A Systematic Review and Meta-analysisAmalie Rehde, Sebastian Kjærgaard Hendel, Carsten Bogh Juhl, et al.
Case Reports in Gastrointestinal Medicine|November 11, 2016
Hemorrhage from Extra-Antral Gastric Antral Vascular Ectasia in a Patient with Duodenal Heterotopic Gastric MucosaJohn Gubatan, Nathan Raines, Hasan Khosravi, et al.
Drugs|November 12, 2024
Immunogenicity of Therapeutic Antibodies Used for Inflammatory Bowel Disease: Treatment and Clinical ConsiderationsOle Haagen Nielsen, Alexander Hammerhøj, Mark Andrew Ainsworth, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 9, 2016
Low Serum Vitamin D During Remission Increases Risk of Clinical Relapse in Patients With Ulcerative ColitisJohn Gubatan, Shuji Mitsuhashi, Talia Zenlea, et al.
World Journal of Gastroenterology|December 10, 2021
Antimicrobial peptides and the gut microbiome in inflammatory bowel diseaseJohn Gubatan, Derek R Holman, Christopher J Puntasecca, et al.
World Journal of Gastroenterology|May 19, 2021
Artificial intelligence applications in inflammatory bowel disease: Emerging technologies and future directionsJohn Gubatan, Steven Levitte, Akshar Patel, et al.
World Journal of Gastroenterology|November 7, 2022
Immune checkpoint inhibitor-mediated colitis is associated with cancer overall survivalAlexa R Weingarden, John Gubatan, Sundeep Singh, et al.
Digestive Diseases and Sciences|March 19, 2024
Some Drugs Have Two Faces: Paradoxical Colitis in a Patient with Psoriatic Arthritis Previously Treated with Etanercept and IL-17 InhibitorsSandy Huynh, Sudharshan Achalu, Rani Berry, et al.
Cytokine|January 12, 2018
Higher serum vitamin D levels are associated with protective serum cytokine profiles in patients with ulcerative colitisJohn Gubatan, Shuji Mitsuhashi, Maria Serena Longhi, et al.
Clinical and Experimental Gastroenterology|September 1, 2021
Anti-Integrins for the Treatment of Inflammatory Bowel Disease: Current Evidence and PerspectivesJohn Gubatan, Kian Keyashian, Samuel J S Rubin, et al.
Pageof 6